Colorectal cancer surgery aims to achieve complete anatomical removal of intestinal neoplasms with negative surgical margins and thorough regional lymphadenectomy. Operating within the discipline of surgical oncology, procedures range from localized segmental bowel resections to complex mesorectal excisions. Surgery functions as a curative modality for early and locally advanced disease and as a palliative intervention for symptomatic complications such as intestinal obstruction or perforation.

Colorectal cancer surgery follows a precise intraoperative sequence. After general anesthesia and endotracheal intubation, the abdomen is accessed via open laparotomy, laparoscopy, or robotic trocars. The abdominal cavity is systematically explored to rule out peritoneal carcinomatosis. The primary blood vessels supplying the tumor-bearing bowel segment are identified, ligated at their vascular origin (high ligation), and divided to optimize lymph node retrieval. The intestine is mobilized along anatomical embryological planes. An en bloc resection of the tumor, neighboring bowel, and attached mesentery is performed with proximal and distal clear margins. Intestinal continuity is restored by creating a primary anastomosis (stapled or hand-sewn) between healthy bowel segments. If primary anastomosis is unsafe due to tissue inflammation, poor perfusion, or emergency conditions, a temporary or permanent stoma (colostomy or ileostomy) is constructed. The surgical field is inspected for homeostasis, and incisions are closed in layers.

Surgical resection offers the highest probability of long-term disease-free survival and cure for localized colorectal cancer. Key clinical benefits include immediate primary tumor removal, elimination of regional nodal micrometastases, accurate pathological staging, and prevention or relief of intestinal obstruction. Minimally invasive surgical techniques, such as laparoscopy and robotic surgery, significantly reduce post-operative pain, shorten hospital stay duration, and accelerate functional recovery without compromising oncological outcomes.

Inpatient hospitalization typically lasts 3 to 7 days under standard Enhanced Recovery After Surgery (ERAS) protocols. Patients begin oral fluids and early ambulation within 24 hours of surgery. Return of normal bowel function (flatus and bowel movements) generally occurs within 2 to 5 days. Full systemic physical recovery, including return to unrestricted daily activity and work, typically takes 4 to 8 weeks, depending on whether surgery was performed via an open, laparoscopic, or robotic approach.

Colorectal cancer surgery treats adenocarcinoma of the colon and rectum, gastrointestinal stromal tumors (GIST), neuroendocrine carcinomas, large dysplastic colorectal polyps unamenable to endoscopic resection, and recurrent local malignant disease. It is also indicated for acute oncological emergencies, including malignant bowel obstruction, intestinal perforation, and uncontrolled tumor hemorrhage.

Pre-operative preparation begins 2 to 4 weeks prior to surgery. Patients undergo complete staging with contrast-enhanced chest, abdomen, and pelvis computed tomography (CT), high-resolution pelvic MRI (for rectal cancer), baseline serum carcinoembryonic antigen (CEA) blood testing, and cardiac/respiratory clearing. Physical optimization includes prehabilitation exercise programs, smoking and alcohol cessation, and nutritional supplementation. Dietary modifications start 48 hours prior to surgery, transitioning to a clear liquid diet. Mechanical bowel preparation (oral osmotic laxative solutions) combined with oral non-absorbable antibiotics is administered the day before surgery according to ASCRS guidelines to reduce surgical site infection risks. Intravenous prophylactic antibiotics and venous thromboembolism prophylaxis (low-molecular-weight heparin and sequential compression devices) are initiated immediately before anesthesia induction.

Complications associated with colorectal cancer surgery include anastomotic leakage (breakdown of the reconnected bowel, occurring in 2-8% of cases), surgical site infection (superficial or deep intra-abdominal abscess), post-operative ileus (temporary bowel paralysis), intra-abdominal hemorrhage, accidental injury to adjacent structures (ureters, urinary bladder, major blood vessels, autonomic nerves), deep vein thrombosis, pulmonary embolism, and cardiopulmonary complications. Long-term risks include incisional hernia formation, abdominal adhesions causing small bowel obstruction, low anterior resection syndrome (LARS) following low rectal resections, urinary dysfunction, and sexual dysfunction due to pelvic nerve injury.

The clinical surgical journey begins with diagnostic staging using colonoscopy, high-resolution cross-sectional imaging, and laboratory evaluations. During the pre-operative phase, patients undergo risk stratification, prehabilitation, and bowel preparation. The intraoperative phase involves general anesthesia, oncological resection, lymph node harvesting, and primary reconstruction or stoma creation. Post-operative care follows Enhanced Recovery After Surgery (ERAS) pathways, focusing on early mobilization, pain control, and dietary progression, followed by long-term surveillance.